DNA2.0 | GenomeWeb

DNA2.0

Genome Compiler will integrate DNA2.0's gene synthesis services into its computer-aided synthetic biology design platform.

NEW YORK (GenomeWeb) – Synthetic biology startup Pareto Biotechnologies announced today a technology partnership with DNA2.0 to integrate their technologies to hasten the engineering of proteins in Pareto's pipeline.

Genome Compiler Corp. (GCC) has agreed to license a patent that covers the technology underlying DNA2.0's Gene Designer software, putting an end to a patent infringement lawsuit between the companies.

Genome Compiler Corporation has asked the US Patent and Trademark Office to reexamine the legal document at the heart of an ongoing lawsuit filed against the company by competing gene synthesis firm DNA2.0 just over a year ago.

Desktop Genetics, a UK-based bioinformatics company, said this week that it will use £375,000 ($582,000) in funding to further develop and commercialize AutoClone, its flagship software product for designing, constructing, managing, and exchanging DNA constructs.

Gene synthesis firm DNA2.0 has filed suit against bioinformatics company Genome Compiler Corporation for allegedly infringing a patent related to GeneDesigner, DNA2.0's software for designing custom gene sequences.

NEW YORK (GenomeWeb News) – DNA2.0 today announced a deal with Newcastle University to develop a protein expression system for Bacillus subtillis.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – DNA2.0 on Monday announced a deal with Cosmo Bio to distribute DNA2.0's complete line of bioengineering products.
Financial and other terms of the deal were not disclosed.

By Uduak Grace Thomas
Researchers in the synthetic biology community are developing a new language intended to standardize the way scientists describe and exchange biological parts, modules, and systems.

People in the News

Premium

DNA2.0, a provider of bioengineering solutions, has named Walter Tian as its senior vice president for marketing and corporate strategy.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.